Sotera Health (SHC) director awarded 14,970 RSUs, now holds 89,882 shares
Rhea-AI Filing Summary
Wheadon David E. reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director David E. Wheadon received an equity grant of 14,970 restricted stock units (RSUs). The RSUs were awarded at no cash cost under the Sotera Health Company 2020 Omnibus Incentive Plan, as part of his compensation for serving as a non-employee director.
Each RSU represents the right to receive one share of common stock, subject to vesting. The grant vests in full on the earlier of the first anniversary of the grant date or immediately before the company’s next regular annual shareholders meeting, if he remains a director. Following this grant, he holds 89,882 shares and RSUs in total, consisting of 14,970 RSUs and 74,912 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 14,970 shares
Net Buy
1 txn
Insider
Wheadon David E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value per share ("Common Stock") | 14,970 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock, $0.01 par value per share ("Common Stock") — 89,882 shares (Direct)
Footnotes (2)
- F1. These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
- F2. These securities consist of 14,970 RSUs and 74,912 shares of Common Stock.
Key Figures
RSU grant size: 14,970 RSUs
Grant price: $0.00 per share
Total holdings after grant: 89,882 shares/RSUs
+3 more
6 metrics
RSU grant size
14,970 RSUs
Equity award granted on May 22, 2026
Grant price
$0.00 per share
Stated transaction price for RSU award
Total holdings after grant
89,882 shares/RSUs
Reported total ownership following the transaction
Common stock held
74,912 shares
Common Stock held in addition to RSUs
RSUs included in holdings
14,970 RSUs
Portion of total holdings represented by unvested RSUs
Vesting trigger
Earlier of 1-year anniversary or next annual meeting
Vesting condition for RSU grant
Key Terms
restricted stock units, RSUs, 2020 Omnibus Incentive Plan, non-employee director
4 terms
restricted stock units financial
"These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
2020 Omnibus Incentive Plan financial
"pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan."
non-employee director financial
"subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Sotera Health (SHC) director David E. Wheadon report on this Form 4?
David E. Wheadon reported receiving 14,970 restricted stock units as an equity award. These RSUs are compensation for his role as a non-employee director and were granted at no cash cost under Sotera Health’s 2020 Omnibus Incentive Plan.
How many Sotera Health (SHC) RSUs were granted to David E. Wheadon?
He was granted 14,970 restricted stock units. Each RSU represents the right to receive one share of Sotera Health common stock, subject to vesting conditions tied to his continued service as a non-employee director on the company’s board.
What are the vesting terms of David E. Wheadon’s 14,970 Sotera Health RSUs?
The 14,970 RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before Sotera Health’s next regular annual shareholders meeting, provided Wheadon continues serving as a non-employee director through the applicable vesting date.
Was this Sotera Health (SHC) Form 4 transaction an open-market stock purchase or sale?
No, the transaction was classified as a grant or award acquisition, not a market trade. Wheadon received 14,970 RSUs at a stated price of $0.00 per share as equity compensation rather than buying or selling shares on the open market.